Vice President of Business Development shares insight on industry trends and bringing drugs to market faster.

3Q Earnings: $186 million (earnings were $1.6B 3Q24) YTD Revenues: $44.5 billion (+8%) YTD Earnings: $2.4 billion (-44%) ...

Merck has entered a definitive agreement to acquire Cidara Therapeutics, a biotechnology company developing drug-Fc conjugate ...

TandemAI has secured a $22 million Series A extension to further develop its drug discovery platform, which combines advanced ...

Global biopharmaceutical sales were $16.3 billion, down 6%. Primary Care sales were down 16% to $7.6 billion. Eliquis sales were up 22% to $2.0 billion. Prevnar sales were down 3% to $1.7 billion.

Q Earnings: $5.8 billion (+83%) YTD Revenues: $48.6 billion (flat) YTD Earnings: $15.3 (+14%) Comments: KEYTRUDA sales were up 10% to $8.1 billion driven by continued global demand and uptake in ...

The U.S. Department of Health and Human Services (HHS) and the U.S. FDA, has appointed Richard Pazdur, M.D., as director of ...

Domain Therapeutics, a clinical-stage biopharmaceutical company, has appointed Jean-Marie Cuillerot, M.D., as Chief Medical ...

Neurvati Neurosciences, the neuroscience development platform of Blackstone Life Sciences, appointed Carlos Martin as Chief ...

BostonGene and Kyoto University have entered a research collaboration to develop advanced biological signatures.

Tech transfer in oral solid dose (OSD) manufacturing is one of the most critical, and often underestimated, phases in the ...

Sarah Cannon Research Institute (SCRI) and Bristol Myers Squibb have announced an expanded strategic collaboration.